News & Info


Page 10 of 29« First...89101112...20...Last »

October 15, 2014

Stem Cell Trial Yields Surprising Results

Posted in: Latest News, Research and Developments

by Dan Roberts Advanced Cell Technology, Inc. (now owned by Astellas) has been conducting promising safety trials for stem cell treatment of macular degeneration, but a six-month follow up has yielded even better news than expected. ACT announced that Phase 1/2 clinical data treatment of Stargardt’s macular degeneration (SMD) and dry age-related macular degeneration (AMD). Surprising even
read more »

October 9, 2014

FDA Grants Priority Review for Lucentis in Diabetic Retinopathy

Posted in: Latest News

Genentech has announced that the FDA has granted its submission for Priority Review of Lucentis® (ranibizumab injection) for the treatment of diabetic retinopathy, an eye disease that impacts nearly 7.7 million Americans. The FDA confirmed action date is February 6, 2015. If approved, Lucentis could be the first eye medicine available for diabetic retinopathy patients. Lucentis
read more »

October 3, 2014

Opportunity to Share Your AMD Experience

Posted in: Latest News

If you or a loved one has Advanced Dry Macular Degeneration (AMD)/Geographic Atrophy (GA), we want to hear from you. Genentech, a leading biotechnology corporation, is looking for people who suffer from or who have a loved one who lives with AMD/GA to share their personal experiences in an upcoming focus group. Travel and lodging
read more »

September 30, 2014

FDA Approves Two Extended-Release Drug Therapies For DME

Posted in: Latest News, Therapies, Treatments, and Procedures

By Dan Roberts Implants devised by two different companies for treatment of diabetic macular edema (DME) have been approved by the FDA for use in the United States. The companies are Allergan and Alimera, and the new drugs are Ozurdex and Iluvien respectively. Both drugs are corticosteroids that have demonstrated effectiveness in the treatment of
read more »

September 25, 2014

Final Stargardt Patient Treated In Initial Stem Cell Trial

Posted in: Latest News

Advanced Cell Technology (ACT) has treated the final patient in the UK-based Phase 1 clinical trial evaluating the safety and tolerability of the company’s stem cell therapy for Stargardt’s disease. To date, no adverse events have been reported. The company is working with U.S. and European regulators to commence a Phase 2 trial to assess
read more »

September 23, 2014

Gene Profiling Technique Accelerates Stem Cell Therapies for Retinal Diseases

Posted in: Latest News, Research and Developments

(Source: National Eye Institute, National Institutes of Health) Researchers at the National Institutes of Health have developed a technique that will streamline the production of stem-cell derived tissues. The technique will help the researchers in their efforts to use patients’ skin cells to create new retinal tissue, a therapy that has been recently applied to
read more »

September 13, 2014

Woman Receives Retinal Stem Cells Made From Her Own Skin

Posted in: Latest News

On September 12, 2014, researchers at the RIKEN Center for Developmental Biology in Japan surgically transplanted into the eye of a woman a sheet of retinal pigment cells made from her own skin. This marks the first time stem cells from a person’s own body have been induced to become retinal cells and implanted into
read more »

August 27, 2014

Podcast Features PB Editor Dan Roberts

Posted in: Latest News

This week’s Eyes on Success podcast features Dan Roberts, Editor-in-Chief at Prevent Blindness and Founding Director of Macular Degeneration Support. He shares his thoughts on navigating the life-changing transition from vision to visual impairment, which he experienced first-hand. Hosts Peter and Nancy Torpey also talk with him about resources and support groups that he maintains,
read more »

August 12, 2014

Low Vision Conferences Becoming High-Tech Accessible

Posted in: Latest News

Organizations for the blind and visually impaired will soon be able to provide indoor navigation technology at their national conferences. The service, called “Audio Guide”, is being offered free gratis to charitable organizations by Macular Degeneration Support, with financial backing by Macular Degeneration Foundation. Beginning in 2015, conference attendees will be able to more easily
read more »

July 30, 2014

Eylea Approved For Diabetic Macular Edema

Posted in: Latest News

Regeneron Pharmaceuticals has announced that the FDA has approved Eylea (aflibercept) injection for treatment of diabetic macular edema (DME) in the U.S. Eylea now joins Genentech’s Lucentis (ramabizumab) as a treatment for DME in addition to neovascular (wet) age-related macular degeneration and macular edema after central retinal vein occlusion. Aflibercept has also been approved for
read more »

July 9, 2014

New Approach to Low Vision Rehab Cuts Risk of Depression in Half

Posted in: Latest News, Low Vision Rehabilitation

Depression is a common risk for people who have lost their vision, but a new study shows that a new approach called “behavior activation” can cut the risk in half. Researchers from Wilmer Eye Institute, Sidney Kimmel Medical College, and Wills Eye Hospital have announced results from their Low Vision Depression Prevention Trial (VITAL), designed
read more »

July 7, 2014

Catching The Big One

Posted in: Latest News

by Dan Roberts Caregivers of older adults have understandable concerns about potential suicide when their loved ones begin talking about death. They may, however, be worrying unnecessarily. During those moments, three questions need to be considered: 1. Is the person depressed? 2. Is the person suicidal? 3. Is the person simply sharing personal thoughts? Risk
read more »

July 4, 2014

Myopia: Genetic or Environmental?

Posted in: Eye Conditions, Latest News

by Dan Roberts Ophthalmic nearsightedness (myopia) results from an abnormal elongation of the eyeball during the growing years. This extra “axial length” causes objects at a distance to appear out of focus, which can usually be corrected with prescription glasses. The physical aspects of extreme nearsightedness (hypermyopia), however, can lead to a type of uncorrectable
read more »

June 25, 2014

Blindness Can Be Prevented Now

Posted in: Daily Living, Latest News

Editorial by Dan Roberts, Editor-in-Chief Prevent Blindness Since 1908, Prevent Blindness has been living up to its name by educating the public about early prevention and detection. It has done this by way of vision screenings, educational programs, research support, and advocacy. But the organization hasn’t stopped there. It realizes that preventing blindness means more
read more »

June 24, 2014

New research on UV rays and cataract

Posted in: Latest News, Research and Developments

Courtesy: National Eye Institute, National Institutes of Health (NEI/NIH) A new study offers an explanation for how years of chronic sunlight exposure can increase the risk of cataract, a clouding of the eye lens that typically occurs with aging. The study firms up a link between the sun’s damaging rays and a process called oxidative
read more »

Page 10 of 29« First...89101112...20...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann